Title : TAK242 suppresses the TLR4 signaling pathway and ameliorates DCD liver IRI in rats.

Pub. Date : 2019 Sep

PMID : 31257518






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The present study was designed to investigate whether TAK242, a specific TLR4 inhibitor, improves hepatic IRI following a DCD graft and to investigate its underlying protective mechanisms. ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate toll-like receptor 4 Rattus norvegicus
2 Additionally, TAK242 significantly inhibited the IRI-associated inflammatory response, indicated by the decreased expression of TLR4, interleukin (IL)-1beta, IL-6 and cyclooxygenase 2 at the mRNA and protein levels (P<0.05). ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate toll-like receptor 4 Rattus norvegicus